Measles-containing-vaccine second-dose (MCV2) … MCV2, WUENIC in Estonia
Estonia: Measles-containing-vaccine second-dose (MCV2) immunization coverage was 75.0% in 2025. ▼ Falling
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Estonia, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, measles-containing-vaccine second-dose (mcv2) immunization coverage in Estonia stood at 75.0%.
That represents a change of up 1.4% on the previous year and down 18.5% over ten years.
Over the whole period, measles-containing-vaccine second-dose (mcv2) immunization coverage in Estonia peaked at 98.0% in 2005 and was at its lowest, 74.0%, in 2024.
That places Estonia 127th out of 194 countries with data for 2025, putting it in the middle of the range.
The long-run direction has been consistently falling across the 26 years of available data.
Measles-containing-vaccine second-dose (MCV2) immunization coverage in Estonia, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 89.0% | — |
| 2001 | 84.0% | -5.6% |
| 2002 | 94.0% | +11.9% |
| 2003 | 96.0% | +2.1% |
| 2004 | 97.0% | +1.0% |
| 2005 | 98.0% | +1.0% |
| 2006 | 98.0% | +0.0% |
| 2007 | 96.0% | -2.0% |
| 2008 | 97.0% | +1.0% |
| 2009 | 96.0% | -1.0% |
| 2010 | 95.0% | -1.0% |
| 2011 | 95.0% | +0.0% |
| 2012 | 94.0% | -1.1% |
| 2013 | 92.0% | -2.1% |
| 2014 | 93.0% | +1.1% |
| 2015 | 92.0% | -1.1% |
| 2016 | 92.0% | +0.0% |
| 2017 | 91.0% | -1.1% |
| 2018 | 88.0% | -3.3% |
| 2019 | 90.0% | +2.3% |
| 2020 | 87.0% | -3.3% |
| 2021 | 84.0% | -3.4% |
| 2022 | 81.0% | -3.6% |
| 2023 | 77.0% | -4.9% |
| 2024 | 74.0% | -3.9% |
| 2025 | 75.0% | +1.4% |
Estonia compared with similar countries
- Estonia's 75.0% is below the median for high income countries, which is 92.0%, 82% of the median. (63 countries reporting)
- Estonia's 75.0% is below the median for Europe & Central Asia, which is 90.0%, 83% of the median. (51 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 94.5% | 84.0% | 98.0% | 10 |
| 2010s | 92.2% | 88.0% | 95.0% | 10 |
| 2020s | 79.7% | 74.0% | 87.0% | 6 |
Countries ranked near Estonia
More health data for Estonia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -1.02 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,416 deaths per 1,000 people (2090)
- Number of infants who die before age 1 3 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -6.8 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.021 units per person (2025)
- Population ages 00-04, male, annual growth rate -6.34 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is measles-containing-vaccine second-dose (mcv2) immunization coverage in Estonia?
- Measles-containing-vaccine second-dose (mcv2) immunization coverage in Estonia was 75.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Estonia?
- The highest recorded value was 98.0% in 2005.
- What is the lowest measles-containing-vaccine second-dose (mcv2) immunization coverage recorded in Estonia?
- The lowest recorded value was 74.0% in 2024.
- How does Estonia rank for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Estonia ranks 127th out of 194 countries with data for 2025.
- Is measles-containing-vaccine second-dose (mcv2) immunization coverage rising or falling in Estonia?
- Over the last ten years it is down 18.5%. The long-run trend across the full record is falling.
- Where does this Estonia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).